Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Feb 6, 2009

Premium

Aruna Biomedical announced last week that it will make its hN2 cells commercially available to the research community in early 2009.

The cells, derived from National Institutes of Health-registered human embryonic cell lines, are offered as a normal, consistent population of neural cells in an adherent monolayer format. The hN2 cells provide a human cell-based format for research ranging from Alzheimer’s disease to spinal cord injury and depression.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.